Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

[Medicine and Nephrology from Social Networks].

Montinaro V, Cianciotta F, Colucci V, D'Ettorre G, Gallo P, Gilberti M, Gintoli E, Matino S, Mercurio U, Montinaro A, Villani C.

G Ital Nefrol. 2018 May;35(3). pii: 2018-vol3. Italian. No abstract available.

PMID:
29786182
2.

LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis.

Peltzer N, Darding M, Montinaro A, Draber P, Draberova H, Kupka S, Rieser E, Fisher A, Hutchinson C, Taraborrelli L, Hartwig T, Lafont E, Haas TL, Shimizu Y, Böiers C, Sarr A, Rickard J, Alvarez-Diaz S, Ashworth MT, Beal A, Enver T, Bertin J, Kaiser W, Strasser A, Silke J, Bouillet P, Walczak H.

Nature. 2018 May;557(7703):112-117. doi: 10.1038/s41586-018-0064-8. Epub 2018 Apr 25.

PMID:
29695863
3.

[Medicine and Nephrology from Social Networks].

Montinaro V, Covella B, D'Ettorre G, Fiorentino M, Gilberti M, Matino S, Montinaro A, Taurisano M, Villani C.

G Ital Nefrol. 2018 Mar;35(2). pii: 2018-vol2. Italian. No abstract available.

PMID:
29582956
4.

Sterile Inflammation Fuels Gastric Cancer.

Montinaro A, Walczak H.

Immunity. 2018 Mar 20;48(3):481-483. doi: 10.1016/j.immuni.2018.03.011.

PMID:
29562199
5.

Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells.

Kolluri KK, Alifrangis C, Kumar N, Ishii Y, Price S, Michaut M, Williams S, Barthorpe S, Lightfoot H, Busacca S, Sharkey A, Yuan Z, Sage EK, Vallath S, Le Quesne J, Tice DA, Alrifai D, von Karstedt S, Montinaro A, Guppy N, Waller DA, Nakas A, Good R, Holmes A, Walczak H, Fennell DA, Garnett M, Iorio F, Wessels L, McDermott U, Janes SM.

Elife. 2018 Jan 18;7. pii: e30224. doi: 10.7554/eLife.30224.

6.

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators.

N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27.

7.

Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy.

von Karstedt S, Montinaro A, Walczak H.

Nat Rev Cancer. 2017 May 24;17(6):352-366. doi: 10.1038/nrc.2017.28. Review.

PMID:
28536452
8.

The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.

Hartwig T, Montinaro A, von Karstedt S, Sevko A, Surinova S, Chakravarthy A, Taraborrelli L, Draber P, Lafont E, Arce Vargas F, El-Bahrawy MA, Quezada SA, Walczak H.

Mol Cell. 2017 Feb 16;65(4):730-742.e5. doi: 10.1016/j.molcel.2017.01.021.

9.

Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis.

von Karstedt S, Conti A, Nobis M, Montinaro A, Hartwig T, Lemke J, Legler K, Annewanter F, Campbell AD, Taraborrelli L, Grosse-Wilde A, Coy JF, El-Bahrawy MA, Bergmann F, Koschny R, Werner J, Ganten TM, Schweiger T, Hoetzenecker K, Kenessey I, Hegedüs B, Bergmann M, Hauser C, Egberts JH, Becker T, Röcken C, Kalthoff H, Trauzold A, Anderson KI, Sansom OJ, Walczak H.

Cancer Cell. 2015 Apr 13;27(4):561-73. doi: 10.1016/j.ccell.2015.02.014. Epub 2015 Apr 2.

10.

Primary intraoperative transluminal angioplasty: a new approach to reduce the early failure of distal arteriovenous fistulas.

Napoli M, Lefons ML, Mangione D, Montagna C, Montagna E, Montinaro AM, Pati C, Sandri G, Sozzo E, Stefanizzi S.

J Vasc Access. 2015 May-Jun;16(3):250-4. doi: 10.5301/jva.5000327. Epub 2015 Jan 17.

PMID:
25613144
11.

HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death.

Peltzer N, Rieser E, Taraborrelli L, Draber P, Darding M, Pernaute B, Shimizu Y, Sarr A, Draberova H, Montinaro A, Martinez-Barbera JP, Silke J, Rodriguez TA, Walczak H.

Cell Rep. 2014 Oct 9;9(1):153-165. doi: 10.1016/j.celrep.2014.08.066. Epub 2014 Oct 2.

12.

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells.

Tuthill MH, Montinaro A, Zinngrebe J, Prieske K, Draber P, Prieske S, Newsom-Davis T, von Karstedt S, Graves J, Walczak H.

Oncogene. 2015 Apr 16;34(16):2138-2144. doi: 10.1038/onc.2014.156. Epub 2014 Jun 9.

13.

[The bilateral renal lymphoma: an incurable disease? Case report].

Napoli M, Montinaro AM, D'Ambrosio E, Di Renzo N, Ambrosino C, Lefons M, Pati C, Sozzo E.

G Ital Nefrol. 2014 Jan-Feb;31(1). pii: gin/31.1.13. Italian.

PMID:
24671846
14.

Ubiquitin in the immune system.

Zinngrebe J, Montinaro A, Peltzer N, Walczak H.

EMBO Rep. 2014 Jan;15(1):28-45. doi: 10.1002/embr.201338025. Epub 2013 Dec 27. Review. Erratum in: EMBO Rep. 2014 Mar;15(3):322.

15.

Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1.

Lemke J, von Karstedt S, Abd El Hay M, Conti A, Arce F, Montinaro A, Papenfuss K, El-Bahrawy MA, Walczak H.

Cell Death Differ. 2014 Mar;21(3):491-502. doi: 10.1038/cdd.2013.179. Epub 2013 Dec 20.

16.

[ANMCO/SICI-GISE document on antiplatelet therapy in patients with acute coronary syndrome].

De Luca L, Bolognese L, Valgimigli M, Ceravolo R, Danzi GB, Piccaluga E, Rakar S, Cremonesi A, Bovenzi FM; Gruppo di Lavoro dell'Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Societa Italiana di Cardiologia Invasiva (SICI-GISE).

G Ital Cardiol (Rome). 2013 Dec;14(12):839-66. doi: 10.1714/1371.15242. Italian.

PMID:
24336601
17.

Adenosine receptors as potential targets in melanoma.

Montinaro A, Iannone R, Pinto A, Morello S.

Pharmacol Res. 2013 Oct;76:34-40. doi: 10.1016/j.phrs.2013.07.002. Epub 2013 Jul 13. Review.

PMID:
23856527
18.

Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial).

Patti G, Pasceri V, Mangiacapra F, Colonna G, Vizzi V, Ricottini E, Montinaro A, D'Ambrosio A, Wijns W, Barbato E, Di Sciascio G; ARMYDA-8 RELOAD-ACS Investigators.

Am J Cardiol. 2013 Jul 15;112(2):162-8. doi: 10.1016/j.amjcard.2013.03.008. Epub 2013 Apr 18.

PMID:
23601577
19.

Adoptive immunotherapy with Cl-IB-MECA-treated CD8+ T cells reduces melanoma growth in mice.

Montinaro A, Forte G, Sorrentino R, Luciano A, Palma G, Arra C, Adcock IM, Pinto A, Morello S.

PLoS One. 2012;7(9):e45401. doi: 10.1371/journal.pone.0045401. Epub 2012 Sep 24.

20.

Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma.

Forte G, Sorrentino R, Montinaro A, Luciano A, Adcock IM, Maiolino P, Arra C, Cicala C, Pinto A, Morello S.

J Immunol. 2012 Sep 1;189(5):2226-33. doi: 10.4049/jimmunol.1200744. Epub 2012 Jul 23.

Supplemental Content

Loading ...
Support Center